The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prognostic significance of performance status in patients with head and neck squamous cell carcinomas (HNSCC) receiving immune checkpoint monoclonal antibodies (ICmAB) in a single institution.
 
Victoria Hwang
No Relationships to Disclose
 
Renato G. Martins
Research Funding - Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Eisai (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Lilly (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Pfizer (Inst)
 
Keith D. Eaton
Research Funding - Mirati Therapeutics (Inst); Pfizer (Inst); Resolution Bioscience (Inst)
 
Laura Quan Man Chow
Honoraria - Amgen; Emergent BioSolutions; Novartis
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Emergent BioSolutions; genzyme; Merck; Novartis; pfizer; Seagen
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Incyte (Inst); Lilly/ImClone (Inst); Merck (Inst); NCCN/Glaxo-Smith Kline (Inst); Novartis (Inst); Pfizer (Inst); VentiRx (Inst)
 
Christina S. Baik
Consulting or Advisory Role - Novartis
Research Funding - Celgene (Inst); Clovis Oncology (Inst); Genentech (Inst); Millennium (Inst); Novartis (Inst)
 
Bernardo H. L. Goulart
No Relationships to Disclose
 
Sylvia Mina Lee
No Relationships to Disclose
 
Rafael Santana-Davila
Consulting or Advisory Role - ARIAD; Eisai; Seagen
Research Funding - Genentech (Inst); Lilly (Inst)
 
Cristina P. Rodriguez
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Ignyta (Inst); Merck (Inst)